Note: Ingredients listed on restricted chemical lists
EC/CAS
56073-10-0
Name of the chemical
Brodifacoum (ISO); 4-Hydroxy-3-(3-(4′-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)cumarin (2016/1179)
Concentration
N/A
General Information
Revision date
2016-07-01
Product name
Rodex B Rodenticide Pellets
CAS No.
56073-10-0
Emergency telephone
1800 024 973 (24 hours
Icons in SDS
Company Information
company name
Adama Australia Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H372
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Hazard statements
This product is classified as: Hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA and IMDG/IMSBC criteria. H302: Harmful if swallowed. H372: Causes damage to organs through prolonged or repeated exposure.
SUSMP Classification
S6
ADG classification
None allocated. Not a Dangerous Good
UN Number
None allocated
Signal word
DANGER Acute Toxicity Oral Category 4 Specific Target Organ toxicity - repeated exposure Category 1
Prevention
P102: Keep out of reach of children. P260: Do not breathe dusts. P262: Do not get in eyes, on skin, or on clothing. P264: Wash contacted areas thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P281: Use personal protective equipment as required.
Response
P314: Get medical advice or attention if you feel unwell. P352: Wash with plenty of soap and water. P301+P312 IF SWALLOWED Call a POISON CENTRE or doctor if you feel unwell P301+P330+P331 IF SWALLOWED Rinse mouth. Do NOT induce vomiting P370+P378: Not combustible. Use extinguishing media suited to burning materials.
Storage
P402+P404: Store in a dry place. Store in a closed container.
Disposal
P501: Dispose of contents and containers as specified on the registered label. Emergency Overview Physical Description & colour: Blue pellets. Odour: Mild odour.
Health hazards
Ingestion of Brodifacoum is initially asymptomatic, and may continue as such even with prolonged alterations in prothrombin time. No gastrointestinal tract or other symptomatology occurs. Coagulation disturbances may become evident a few days after ingestion, and may be detected only by laboratory studies. In severe poisoning, gum-bleeding, epistaxis, petechiae, ecchymoses, haematomata, blood in urine and faeces, and genital haemorrhage may occur. Internal bleeding and cerebral haemorrhage may complicate the patient's prognosis. No major health hazards are known.
